Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Mario Cazzola and Alessandro Vannucchi.
Mario Cazzola
Connection Strength
0.773
Alessandro Vannucchi
  1. Ruxolitinib for essential thrombocythemia refractory to or intolerant of hydroxyurea: long-term phase 2 study results. Blood. 2017 10 12; 130(15):1768-1771.
    View in: PubMed
    Score: 0.182
  2. Prognostic impact of bone marrow fibrosis in primary myelofibrosis. A study of the AGIMM group on 490 patients. Am J Hematol. 2016 09; 91(9):918-22.
    View in: PubMed
    Score: 0.169
  3. Second primary malignancies in postpolycythemia vera and postessential thrombocythemia myelofibrosis: A study on 2233 patients. Cancer Med. 2019 08; 8(9):4089-4092.
    View in: PubMed
    Score: 0.052
  4. Gender effect on phenotype and genotype in patients with post-polycythemia vera and post-essential thrombocythemia myelofibrosis: results from the MYSEC project. Blood Cancer J. 2018 09 21; 8(10):89.
    View in: PubMed
    Score: 0.049
  5. Value of cytogenetic abnormalities in post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a study of the MYSEC project. Haematologica. 2018 09; 103(9):e392-e394.
    View in: PubMed
    Score: 0.048
  6. Benefit-risk profile of cytoreductive drugs along with antiplatelet and antithrombotic therapy after transient ischemic attack or ischemic stroke in myeloproliferative neoplasms. Blood Cancer J. 2018 02 28; 8(3):25.
    View in: PubMed
    Score: 0.047
  7. MIPSS70: Mutation-Enhanced International Prognostic Score System for Transplantation-Age Patients With Primary Myelofibrosis. J Clin Oncol. 2018 02 01; 36(4):310-318.
    View in: PubMed
    Score: 0.047
  8. CALR mutational status identifies different disease subtypes of essential thrombocythemia showing distinct expression profiles. Blood Cancer J. 2017 12 08; 7(12):638.
    View in: PubMed
    Score: 0.047
  9. Recommendations for molecular testing in classical Ph1-neg myeloproliferative disorders-A consensus project of the Italian Society of Hematology. Leuk Res. 2017 07; 58:63-72.
    View in: PubMed
    Score: 0.045
  10. Presentation and outcome of patients with 2016 WHO diagnosis of prefibrotic and overt primary myelofibrosis. Blood. 2017 06 15; 129(24):3227-3236.
    View in: PubMed
    Score: 0.044
  11. The effect of arterial hypertension on thrombosis in low-risk polycythemia vera. Am J Hematol. 2017 Jan; 92(1):E5-E6.
    View in: PubMed
    Score: 0.044
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.